Holen Sie sich die Stockscreener-App
2.49
0.40%
-0.010
Handel nachbörslich:
2.45
-0.04
-1.61%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.47
24-Stunden-Volumen:
54,722
Relative Volume:
0.12
Marktkapitalisierung:
$7.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$2.81M
KGV:
-0.1735
EPS:
-14.3497
Netto-Cashflow:
$7.14M
1W Leistung:
+2.47%
1M Leistung:
-17.00%
6M Leistung:
-30.83%
1J Leistung:
-20.95%
1-Tages-Spanne:
$2.4308
$2.5264
1-Wochen-Bereich:
$2.27
$2.60
52-Wochen-Spanne:
$2.25
$4.29
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Firmenname
Kiora Pharmaceuticals Inc
Sektor
Branche
Telefon
858-224-9600
Adresse
169 SAXONY RD., ENCINITAS
Vergleichen Sie KPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.49 | 7.61M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Aktie (KPRX) Neueste Nachrichten
Statistical indicators supporting Kiora Pharmaceuticals Inc.’s strengthStop Loss & Technical Pattern Based Signals - Newser
Market reaction to Kiora Pharmaceuticals Inc.’s recent newsJuly 2025 Summary & High Yield Equity Trading Tips - Newser
Quantitative breakdown of Kiora Pharmaceuticals Inc. recent moveMarket Weekly Review & Daily Entry Point Alerts - Newser
Kiora Pharmaceuticals Highlights at Ophthalmology Conference - TipRanks
Key metrics from Kiora Pharmaceuticals Inc.’s quarterly dataMarket Performance Report & High Accuracy Trade Alerts - Newser
Ranking Kiora Pharmaceuticals Inc. among high performing stocks via tools2025 Momentum Check & Weekly Chart Analysis and Guides - Newser
Is Kiora Pharmaceuticals Inc. still worth holding after the dipTrade Risk Report & Low Drawdown Trading Techniques - Newser
Kiora Pharmaceuticals Inc. stock momentum explainedFree Real Trader Watchlist of Hot Stocks - Newser
What machine learning models say about Kiora Pharmaceuticals Inc.Institutional Holding Behavior Pattern Analysis - Newser
Kiora Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowMarket Stability and Long-Term Growth Outlook - Newser
Using Ichimoku Cloud for Kiora Pharmaceuticals Inc. technicalsTrend Following Ideas with Volume Confirmation - Newser
Building trade automation scripts for Kiora Pharmaceuticals Inc.Market Ready Picks with Technical Support - Newser
Analyzing drawdowns of Kiora Pharmaceuticals Inc. with statistical toolsFree Weekly Setup With 3x Return Potential - Newser
Kiora Pharmaceuticals Inc. stock trend outlook and recovery pathFree Breakout Entry Signal Confirmation Tool - Newser
Strategies to average down on Kiora Pharmaceuticals Inc.Low-Risk Reversal Pattern Analysis Tracker - Newser
Applying sector rotation models to Kiora Pharmaceuticals Inc.Institutional Holding Behavior Pattern Analysis - Newser
Will Kiora Pharmaceuticals Inc. see short term momentumPredictive Short-Term Market Reversal Alerts - Newser
Using AI based signals to follow Kiora Pharmaceuticals Inc.Trade Safety Report with Pattern Insights - Newser
Can Kiora Pharmaceuticals Inc. stock recover from recent declinePortfolio Risk Distribution Analysis Tool - Newser
Reversal indicators forming on Kiora Pharmaceuticals Inc. stockFree Growth Based Investment Plan Guidance - Newser
Risk vs reward if holding onto Kiora Pharmaceuticals Inc.Swing Trade Timing with Daily Forecast - Newser
What data driven models say about Kiora Pharmaceuticals Inc.’s futureFree Entry Plan for Oversold Reversal Stocks - Newser
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals - TipRanks
Can swing trading help recover from Kiora Pharmaceuticals Inc. lossesFree Weekly Hot Picks With Buy Confidence - Newser
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionMonthly Long-Term Market Recap and Summary - Newser
Kiora (KPRX) Q2 Revenue Falls 100% - AOL.com
Kiora Pharmaceuticals Advances Retinal Disease Pipeline - TipRanks
Abacus Global Management, Inc. shares rise 10.27% intraday after Kiora Pharmaceuticals reported positive Phase 2 clinical trial results for KIO-104. - AInvest
Kiora Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Kiora pharma reports Q2 results, advances retinal disease trials - Investing.com
Kiora's Q2 Earnings Reveal Dual Phase 2 Trials Progress and $110M Asia Partnership Opportunity - Stock Titan
Is Kiora Pharmaceuticals Inc. showing signs of accumulationFree Stable Entry High Return Opportunities - Newser
What makes Kiora Pharmaceuticals Inc. stock price move sharplyReal Time Growth Signal with Smart Setup - Newser
Kiora CEO to Reveal Latest Retinal Disease Therapeutic Developments at Major Ophthalmology Conference - Stock Titan
Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):